Figure 1.
The dose-response relationships between Mets-IR and the risk of new-onset CVD, stroke, and heart disease. (A) Represents the relationship between the Mets-IR and the risk of CVD in restricted cubic spline. (B) Represents the relationship between the Mets-IR and the risk of stroke in restricted cubic spline. (C) Represents the relationship between the Mets-IR and the risk of heart disease in restricted cubic spline.